{"title":"Peptide Blends","description":"","products":[{"product_id":"bpc-157-tb-500-blend-5-5mg-10-10mg","title":"BPC-157, TB-500 Blend","description":"\u003cp data-start=\"0\" data-end=\"483\"\u003eBPC-157 \/ TB-500 is a research peptide blend combining two well-studied synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment TB-500. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturally occurring thymosin beta-4. Together, this blend is formulated for laboratory research focused on tissue repair, angiogenesis, and cellular regeneration pathways.\u003c\/p\u003e\n\u003cp data-start=\"485\" data-end=\"1035\"\u003ePrior to the synthesis and isolation of these peptides, research into accelerated tissue healing and recovery relied largely on broad growth factors and nonspecific interventions. BPC-157 has been shown in research settings to influence angiogenic signaling, nitric oxide pathways, and fibroblast activity, while TB-500 has been studied for its role in actin regulation, cell migration, and wound-healing mechanisms. The combination allows researchers to examine complementary pathways involved in musculoskeletal and connective tissue repair models.\u003c\/p\u003e\n\u003cp data-start=\"1037\" data-end=\"1514\"\u003eCurrently, the BPC-157 \/ TB-500 blend is being investigated for its potential applications in soft tissue regeneration, tendon and ligament repair models, inflammation modulation, and cellular migration studies. Additional research is exploring its role in vascularization processes and recovery pathways following tissue stress or injury. Due to the synergistic research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"1333\" data-start=\"864\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"1578\" data-start=\"1339\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-end=\"1578\" data-start=\"1339\"\u003e\u003cmeta charset=\"utf-8\"\u003e The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"1578\" data-start=\"1339\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nord-Sci","offers":[{"title":"5\/5mg (standard)","offer_id":52873241559358,"sku":null,"price":120.0,"currency_code":"USD","in_stock":true},{"title":"10\/10mg (best value)","offer_id":52873241592126,"sku":null,"price":200.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/BPC-157_TB-500_5_5mg.png?v=1768431666"},{"product_id":"glow-blend-bpc-157-tb-500-ghk-cu-5-5-20mg-10-10-40mg","title":"Glow Blend: BPC-157, TB-500, GHK-Cu","description":"\u003cp data-end=\"585\" data-start=\"0\"\u003eGlow Blend is a research peptide formulation combining BPC-157, TB-500, and GHK-Cu: three peptides widely studied for their roles in tissue repair, cellular regeneration, and extracellular matrix signaling. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, TB-500 is a synthetic peptide modeled after thymosin beta-4, and GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. Together, this blend is designed for laboratory research exploring synergistic regenerative and cellular signaling pathways.\u003c\/p\u003e\n\u003cp data-end=\"1227\" data-start=\"587\"\u003eBefore the development and synthesis of these peptides, research into tissue regeneration and skin remodeling relied largely on isolated growth factors and nonspecific biochemical agents. BPC-157 has been studied for its influence on angiogenesis, nitric oxide signaling, and fibroblast activity, while TB-500 has been researched for its role in actin regulation, cell migration, and wound-healing processes. GHK-Cu has been shown in research settings to modulate gene expression related to collagen synthesis, inflammation regulation, and tissue remodeling, making it a focal point in studies involving dermal and connective tissue models.\u003c\/p\u003e\n\u003cp data-end=\"1694\" data-start=\"1229\"\u003eCurrently, Glow Blend is being investigated for its potential applications in skin regeneration research, wound-healing models, connective tissue repair, and extracellular matrix remodeling studies. Additional research is exploring its role in angiogenic signaling, cellular turnover, and oxidative stress response pathways. Due to the complementary research profiles of these peptides, Glow Blend remains a promising subject for continued laboratory investigation.\u003c\/p\u003e\n\u003cp data-start=\"864\" data-end=\"1333\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1339\" data-end=\"1578\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"1339\" data-end=\"1578\"\u003e\u003cmeta charset=\"utf-8\"\u003e The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-start=\"1339\" data-end=\"1578\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nord-Sci","offers":[{"title":"5\/5\/20mg (standard)","offer_id":52873248571710,"sku":null,"price":165.0,"currency_code":"USD","in_stock":true},{"title":"10\/10\/40mg (best value)","offer_id":52873248604478,"sku":null,"price":315.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Glow_Blend_5_5_30mg.png?v=1768431019"},{"product_id":"klow-blend","title":"Klow Blend: BPC-157, TB-500, KPV, GHK-Cu","description":"\u003cp data-end=\"828\" data-start=\"157\"\u003eKlow Blend is a multi-peptide research formulation combining four extensively studied synthetic peptides: Body Protection Compound-157 (BPC-157), Thymosin Beta-4 fragment TB-500, KPV, and GHK-Cu. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturally occurring thymosin beta-4. KPV is a tripeptide fragment of alpha-melanocyte-stimulating hormone, and GHK-Cu is a naturally occurring copper-binding peptide. Together, this blend is formulated for laboratory research examining cellular repair signaling, inflammatory pathways, and tissue-level regeneration mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1640\" data-start=\"830\"\u003eBefore the targeted synthesis and isolation of these peptides, research into tissue recovery and regenerative processes relied heavily on generalized growth factors and less specific biological agents. In controlled research settings, BPC-157 has been shown to influence angiogenic signaling, nitric oxide pathways, and fibroblast activity. TB-500 has been widely studied for its role in actin regulation, cell migration, and wound-healing dynamics. KPV has been researched for its effects on inflammatory modulation, while GHK-Cu has been examined for its involvement in extracellular matrix signaling, cellular turnover, and regenerative processes. The combined formulation allows researchers to explore multiple complementary mechanisms within musculoskeletal, connective tissue, and cellular repair models.\u003c\/p\u003e\n\u003cp data-end=\"2144\" data-start=\"1642\"\u003eCurrently, Klow Blend is being investigated for potential applications in soft tissue regeneration studies, inflammation signaling research, cellular migration models, and recovery pathways associated with tissue stress or injury. Additional research continues to explore its role in vascularization, collagen remodeling, and coordinated cellular response mechanisms. Due to the combined research interest of these peptides, Klow Blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2385\" data-start=\"2146\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2385\" data-start=\"2146\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2809\" data-start=\"2387\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2809\" data-start=\"2387\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900974985534,"sku":null,"price":395.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Klow_Blend_6a7e1c0d-eeb7-42fe-a4b8-924ba423ab8b.png?v=1768873998"},{"product_id":"cjc-1295-no-dac-ipamorelin-blend","title":"CJC-1295 no DAC, Ipamorelin Blend","description":"\u003cp data-end=\"883\" data-start=\"206\"\u003eCJC-1295 (No DAC) \/ Ipamorelin Blend (5\/5mg) is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone–related signaling research: CJC-1295 without DAC and Ipamorelin. CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog designed without a drug affinity complex to support short-duration signaling studies, while Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin activity without significant impact on cortisol or prolactin pathways. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release and downstream cellular signaling mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1544\" data-start=\"885\"\u003ePrior to the development of these targeted peptides, research into growth hormone stimulation and regulatory pathways relied largely on non-selective secretagogues and broader endocrine interventions. In controlled research environments, CJC-1295 (No DAC) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation, while Ipamorelin has been researched for its selective binding to ghrelin receptors and its role in amplifying growth hormone pulses. The combination allows researchers to examine complementary mechanisms involved in endocrine signaling, metabolic regulation, and cellular recovery models.\u003c\/p\u003e\n\u003cp data-end=\"2038\" data-start=\"1546\"\u003eCurrently, the CJC-1295 (No DAC) \/ Ipamorelin Blend is being investigated for potential applications in growth hormone secretion studies, metabolic signaling research, cellular recovery pathways, and age-related endocrine research models. Additional studies continue to explore its role in circadian hormone rhythm research and anabolic signaling cascades. Due to the synergistic research interest of these peptides, this blend remains a valuable subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2279\" data-start=\"2040\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2279\" data-start=\"2040\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2703\" data-start=\"2281\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2703\" data-start=\"2281\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975313214,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/CJC-1295_No_DAC_Ipamorelin_5_5mg_d3678290-a71f-4000-8885-ada3135f44b3.png?v=1768873999"},{"product_id":"cjc-1295-no-dac-ghrp-2-blend","title":"CJC-1295 no DAC, GHRP-2 Blend","description":"\u003cp data-start=\"196\" data-end=\"808\"\u003eCJC-1295 (No DAC) \/ GHRP-2 Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: CJC-1295 without Drug Affinity Complex (No DAC) and Growth Hormone–Releasing Peptide-2 (GHRP-2). CJC-1295 (No DAC) is a modified growth hormone–releasing hormone (GHRH) analog, while GHRP-2 is a potent growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and metabolic regulation mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"810\" data-end=\"1548\"\u003ePrior to the targeted development and isolation of these peptides, research into growth hormone stimulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, CJC-1295 (No DAC) has been studied for its ability to stimulate endogenous growth hormone release via GHRH receptor activation while maintaining a shorter duration of action compared to DAC-bound variants. GHRP-2 has been widely researched for its strong receptor binding activity and its role in stimulating growth hormone secretion through ghrelin receptor pathways. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, amplitude, and signaling dynamics.\u003c\/p\u003e\n\u003cp data-start=\"1550\" data-end=\"2087\"\u003eCurrently, the CJC-1295 (No DAC) \/ GHRP-2 Blend is being investigated for its potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional studies continue to explore its role in downstream anabolic signaling, circadian hormone patterns, and coordinated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a valuable subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-start=\"2089\" data-end=\"2328\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"2089\" data-end=\"2328\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"2330\" data-end=\"2752\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-start=\"2330\" data-end=\"2752\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975378750,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/CJC-1295_No_DAC_GHRP-2_5_5mg_953df170-6825-48b2-b1d2-555810e658de.png?v=1768874002"},{"product_id":"cjc-1295-no-dac-ghrp-6-blend","title":"CJC-1295 no DAC, GHRP-6 Blend","description":"\u003cp data-end=\"857\" data-start=\"213\"\u003eCJC-1295 (No DAC) \/ GHRP-6 Blend is a research peptide formulation combining two well-studied synthetic peptides frequently examined in growth hormone and endocrine signaling research: CJC-1295 without Drug Affinity Complex (No DAC) and Growth Hormone–Releasing Peptide-6 (GHRP-6). CJC-1295 (No DAC) is a modified growth hormone–releasing hormone (GHRH) analog, while GHRP-6 is a growth hormone secretagogue receptor (GHS-R) agonist originally developed as a hexapeptide. Together, this blend is formulated for laboratory research focused on growth hormone release dynamics, receptor signaling pathways, and metabolic regulation mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1592\" data-start=\"859\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal approaches. In controlled research settings, CJC-1295 (No DAC) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a shorter duration of activity compared to DAC-bound variants. GHRP-6 has been widely researched for its role in ghrelin receptor activation and its effects on growth hormone secretion amplitude and frequency. The combination allows researchers to examine complementary mechanisms involved in pulsatile growth hormone signaling and coordinated pituitary response models.\u003c\/p\u003e\n\u003cp data-end=\"2134\" data-start=\"1594\"\u003eCurrently, the CJC-1295 (No DAC) \/ GHRP-6 Blend is being investigated for potential applications in metabolic research models, endocrine signaling analysis, recovery-related pathways, and age-associated hormone regulation studies. Additional research continues to explore its role in downstream anabolic signaling, appetite-related hormone interactions, and circadian growth hormone release patterns. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2375\" data-start=\"2136\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2375\" data-start=\"2136\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2799\" data-start=\"2377\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2799\" data-start=\"2377\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975411518,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/CJC-1295_No_DAC_GHRP-6_5_5mg_c4c89662-9ae9-4bfc-9cb2-05b46205b23d.png?v=1768874004"},{"product_id":"cjc-1295-no-dac-hexarelin-blend","title":"CJC-1295 no DAC, Hexarelin Blend","description":"\u003cp data-end=\"856\" data-start=\"216\"\u003eCJC-1295 (No DAC) \/ Hexarelin Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: CJC-1295 without Drug Affinity Complex (No DAC) and Hexarelin. CJC-1295 (No DAC) is a modified growth hormone–releasing hormone (GHRH) analog, while Hexarelin is a potent growth hormone secretagogue receptor (GHS-R) agonist derived from the growth hormone–releasing peptide family. Together, this blend is formulated for laboratory research focused on growth hormone release dynamics, receptor activation pathways, and endocrine signaling mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1628\" data-start=\"858\"\u003ePrior to the targeted synthesis and characterization of these peptides, research into growth hormone stimulation relied largely on less selective secretagogues and broader hormonal approaches. In controlled research settings, CJC-1295 (No DAC) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a shorter duration of action compared to DAC-bound variants. Hexarelin has been extensively researched for its strong receptor affinity and its role in stimulating growth hormone secretion via ghrelin receptor pathways. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion amplitude, and coordinated pituitary signaling models.\u003c\/p\u003e\n\u003cp data-end=\"2182\" data-start=\"1630\"\u003eCurrently, the CJC-1295 (No DAC) \/ Hexarelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional research continues to explore its role in downstream anabolic signaling, cardiovascular-related research pathways, and circadian growth hormone release patterns. Due to the complementary research interest of these peptides, this blend remains a valuable subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2182\" data-start=\"1630\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2182\" data-start=\"1630\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2423\" data-start=\"2184\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2847\" data-start=\"2425\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975444286,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/CJC-1295_no_DAC_Hexarelin_5_5mg_5f872668-e886-498a-aad8-8d3098a68bd2.png?v=1768874006"},{"product_id":"cjc-1295-no-dac-ipamorelin-ghrp-2-blend","title":"CJC-1295 no DAC, Ipamorelin, GHRP-2 Blend","description":"\u003cp data-end=\"833\" data-start=\"139\"\u003eCJC-1295 (No DAC) \/ Ipamorelin \/ GHRP-2 Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: CJC-1295 without Drug Affinity Complex (No DAC), Ipamorelin, and Growth Hormone–Releasing Peptide-2 (GHRP-2). CJC-1295 (No DAC) is a modified growth hormone–releasing hormone (GHRH) analog, while Ipamorelin and GHRP-2 are growth hormone secretagogue receptor (GHS-R) agonists with differing receptor activity profiles. Together, this blend is formulated for laboratory research focused on growth hormone pulsatility, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1662\" data-start=\"835\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, CJC-1295 (No DAC) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a shorter duration of activity compared to DAC-bound variants. Ipamorelin has been researched for its selective receptor activity and minimal interaction with other pituitary hormones, while GHRP-2 has been widely studied for its potent receptor binding and influence on growth hormone secretion dynamics. The combination allows researchers to examine complementary mechanisms involved in growth hormone release amplitude, frequency, and signaling coordination.\u003c\/p\u003e\n\u003cp data-end=\"2224\" data-start=\"1664\"\u003eCurrently, the CJC-1295 (No DAC) \/ Ipamorelin \/ GHRP-2 Blend is being investigated for its potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, circadian hormone release patterns, and integrated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2224\" data-start=\"1664\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2224\" data-start=\"1664\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2465\" data-start=\"2226\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2889\" data-start=\"2467\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975509822,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/CJC-1295_no_DAC_Ipamorelin_GHRP-2_Blend_3293a4b6-da36-4151-b841-efa2f7a41f2a.png?v=1768874007"},{"product_id":"fragment-cjc-1295-no-dac-ipamorelin-blend","title":"Fragment, CJC-1295 no DAC, Ipamorelin Blend","description":"\u003cp data-end=\"828\" data-start=\"139\"\u003eFragment \/ CJC-1295 (No DAC) \/ Ipamorelin Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Fragment (176–191), CJC-1295 without Drug Affinity Complex (No DAC), and Ipamorelin. Fragment (176–191) is a modified C-terminal fragment of human growth hormone, while CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog and Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on growth hormone signaling, metabolic pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1663\" data-start=\"830\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation and metabolic signaling relied largely on less specific hormonal interventions and generalized secretagogues. In controlled research settings, Fragment (176–191) has been studied for its role in lipid metabolism–related signaling pathways. CJC-1295 (No DAC) has been researched for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a shorter duration of action compared to DAC-bound variants. Ipamorelin has been examined for its selective receptor activity and minimal interaction with other pituitary hormones. The combination allows researchers to explore complementary mechanisms involved in growth hormone pulsatility, metabolic signaling, and endocrine coordination.\u003c\/p\u003e\n\u003cp data-end=\"2248\" data-start=\"1665\"\u003eCurrently, the Fragment \/ CJC-1295 (No DAC) \/ Ipamorelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic and metabolic signaling processes, circadian hormone release patterns, and coordinated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2489\" data-start=\"2250\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2489\" data-start=\"2250\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2489\" data-start=\"2250\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2913\" data-start=\"2491\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975542590,"sku":null,"price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Fragment_CJC-1295_no_DAC_Ipamorelin_Blend_a8803d0d-1b07-445e-be32-eb4086de2a7d.png?v=1768874009"},{"product_id":"fragment-modified-grf-ipamorelin-blend","title":"Fragment, Modified GRF, Ipamorelin Blend","description":"\u003cp data-end=\"808\" data-start=\"139\"\u003eFragment \/ Modified GRF \/ Ipamorelin Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Fragment (176–191), Modified GRF (1–29), and Ipamorelin. Fragment (176–191) is a modified C-terminal fragment of human growth hormone, while Modified GRF (1–29) is a stabilized analog of growth hormone–releasing hormone (GHRH). Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on growth hormone signaling, metabolic pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1611\" data-start=\"810\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation and metabolic signaling relied largely on less specific hormonal interventions and generalized secretagogues. In controlled research settings, Fragment (176–191) has been studied for its role in lipid metabolism–related signaling pathways. Modified GRF (1–29) has been researched for its ability to stimulate endogenous growth hormone release via GHRH receptor activation while maintaining a short duration of activity. Ipamorelin has been examined for its selective receptor activity and minimal interaction with other pituitary hormones. The combination allows researchers to explore complementary mechanisms involved in growth hormone pulsatility, metabolic regulation, and endocrine coordination.\u003c\/p\u003e\n\u003cp data-end=\"2191\" data-start=\"1613\"\u003eCurrently, the Fragment \/ Modified GRF \/ Ipamorelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic and metabolic signaling processes, circadian hormone release patterns, and coordinated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2432\" data-start=\"2193\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2432\" data-start=\"2193\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2432\" data-start=\"2193\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2856\" data-start=\"2434\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975575358,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Fragment_Modified_GRF_Ipamorelin_Blend_5d44aff3-4696-4980-9f03-e08fa040a832.png?v=1768874010"},{"product_id":"mod-grf-1-29-ghrp-2-blend","title":"Mod GRF (1-29), GHRP-2 Blend","description":"\u003cp data-end=\"754\" data-start=\"151\"\u003eModified GRF (1–29) \/ GHRP-2 Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Modified GRF (1–29) and Growth Hormone–Releasing Peptide-2 (GHRP-2). Modified GRF (1–29) is a stabilized analog of growth hormone–releasing hormone (GHRH), while GHRP-2 is a potent growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1444\" data-start=\"756\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Modified GRF (1–29) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a short duration of activity. GHRP-2 has been widely researched for its strong receptor binding affinity and its influence on growth hormone secretion dynamics. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion amplitude, and signaling coordination.\u003c\/p\u003e\n\u003cp data-end=\"1991\" data-start=\"1446\"\u003eCurrently, the Modified GRF (1–29) \/ GHRP-2 Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, circadian hormone release patterns, and integrated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"1991\" data-start=\"1446\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"1991\" data-start=\"1446\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2232\" data-start=\"1993\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2656\" data-start=\"2234\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975608126,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Mod_GRF_GHRP-2_5_5mg_0790a6df-1d6d-4a7b-9688-2ced82324003.png?v=1768874012"},{"product_id":"mod-grf-1-29-ghrp-6-blend","title":"Mod GRF (1-29), GHRP-6 Blend","description":"\u003cp data-end=\"779\" data-start=\"145\"\u003eModified GRF (1–29) \/ GHRP-6 Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Modified GRF (1–29) and Growth Hormone–Releasing Peptide-6 (GHRP-6). Modified GRF (1–29) is a stabilized analog of growth hormone–releasing hormone (GHRH), while GHRP-6 is a growth hormone secretagogue receptor (GHS-R) agonist originally developed as a hexapeptide. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1486\" data-start=\"781\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Modified GRF (1–29) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a short duration of activity. GHRP-6 has been widely researched for its role in ghrelin receptor activation and its influence on growth hormone secretion amplitude and frequency. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion dynamics, and signaling coordination.\u003c\/p\u003e\n\u003cp data-end=\"2037\" data-start=\"1488\"\u003eCurrently, the Modified GRF (1–29) \/ GHRP-6 Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, appetite-related hormone interactions, and circadian growth hormone release patterns. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2037\" data-start=\"1488\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2037\" data-start=\"1488\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2278\" data-start=\"2039\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2702\" data-start=\"2280\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975640894,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Mod_GRF_GHRP-6_5_5mg_d4f59992-2325-44c1-a4c1-d69146ad6d7c.png?v=1768874014"},{"product_id":"mod-grf-1-29-hexarelin-blend","title":"Mod GRF (1-29), Hexarelin Blend","description":"\u003cp data-end=\"784\" data-start=\"151\"\u003eModified GRF (1–29) \/ Hexarelin Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Modified GRF (1–29) and Hexarelin. Modified GRF (1–29) is a stabilized analog of growth hormone–releasing hormone (GHRH), while Hexarelin is a potent growth hormone secretagogue receptor (GHS-R) agonist derived from the growth hormone–releasing peptide family. Together, this blend is formulated for laboratory research focused on growth hormone release dynamics, receptor activation pathways, and coordinated endocrine signaling mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1516\" data-start=\"786\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Modified GRF (1–29) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a short duration of activity. Hexarelin has been extensively researched for its strong receptor affinity and its role in stimulating growth hormone secretion via ghrelin receptor pathways. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion amplitude, and integrated pituitary response models.\u003c\/p\u003e\n\u003cp data-end=\"2073\" data-start=\"1518\"\u003eCurrently, the Modified GRF (1–29) \/ Hexarelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, cardiovascular-related research pathways, and circadian growth hormone release patterns. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2073\" data-start=\"1518\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2073\" data-start=\"1518\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2314\" data-start=\"2075\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2738\" data-start=\"2316\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975673662,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Mod_GRF_Hexarelin_5_5mg_2a76b794-3610-4a4b-b5c9-5b2e14eaf32d.png?v=1768874015"},{"product_id":"mod-grf-1-29-ipamorelin-ghrp-2-blend","title":"Mod GRF (1-29), Ipamorelin, GHRP-2 Blend","description":"\u003cp data-end=\"826\" data-start=\"151\"\u003eModified GRF (1–29) \/ Ipamorelin \/ GHRP-2 Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Modified GRF (1–29), Ipamorelin, and Growth Hormone–Releasing Peptide-2 (GHRP-2). Modified GRF (1–29) is a stabilized analog of growth hormone–releasing hormone (GHRH), while Ipamorelin and GHRP-2 are growth hormone secretagogue receptor (GHS-R) agonists with differing receptor activity profiles. Together, this blend is formulated for laboratory research focused on growth hormone pulsatility, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1625\" data-start=\"828\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Modified GRF (1–29) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a short duration of activity. Ipamorelin has been examined for its selective receptor activity and minimal interaction with other pituitary hormones, while GHRP-2 has been widely researched for its potent receptor binding and influence on growth hormone secretion dynamics. The combination allows researchers to examine complementary mechanisms involved in growth hormone release amplitude, frequency, and signaling coordination.\u003c\/p\u003e\n\u003cp data-end=\"2185\" data-start=\"1627\"\u003eCurrently, the Modified GRF (1–29) \/ Ipamorelin \/ GHRP-2 Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, circadian hormone release patterns, and integrated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2185\" data-start=\"1627\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2185\" data-start=\"1627\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2426\" data-start=\"2187\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2850\" data-start=\"2428\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975706430,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Mod_GRF_1-29_Ipamorelin_GHRP-2_Blend_d5899a45-7f0e-488f-a3be-b8e03b74ec14.png?v=1768874016"},{"product_id":"mod-grf-1-29-ipamorelin-blend","title":"Mod GRF (1-29), Ipamorelin Blend","description":"\u003cp data-end=\"720\" data-start=\"139\"\u003eModified GRF (1–29) \/ Ipamorelin Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Modified GRF (1–29) and Ipamorelin. Modified GRF (1–29) is a stabilized analog of growth hormone–releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1408\" data-start=\"722\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Modified GRF (1–29) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a short duration of activity. Ipamorelin has been examined for its selective receptor activity and minimal interaction with other pituitary hormones. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion dynamics, and endocrine signaling coordination.\u003c\/p\u003e\n\u003cp data-end=\"1960\" data-start=\"1410\"\u003eCurrently, the Modified GRF (1–29) \/ Ipamorelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, circadian hormone release patterns, and coordinated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"1960\" data-start=\"1410\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"1960\" data-start=\"1410\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2201\" data-start=\"1962\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2625\" data-start=\"2203\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975739198,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Mod_GRF_Ipamorelin_5_5mg_b26f9c97-8b31-4c26-acc0-bf029d014836.png?v=1768874018"},{"product_id":"sermorelin-ghrp-2-blend","title":"Sermorelin, GHRP-2 Blend","description":"\u003cp data-start=\"145\" data-end=\"720\"\u003eSermorelin \/ GHRP-2 Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Sermorelin and Growth Hormone–Releasing Peptide-2 (GHRP-2). Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), while GHRP-2 is a potent growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"722\" data-end=\"1423\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Sermorelin has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation, while maintaining a relatively short duration of activity. GHRP-2 has been widely researched for its strong receptor binding affinity and its influence on growth hormone secretion dynamics. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion amplitude, and endocrine signaling coordination.\u003c\/p\u003e\n\u003cp data-start=\"1425\" data-end=\"1961\"\u003eCurrently, the Sermorelin \/ GHRP-2 Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, circadian hormone release patterns, and integrated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-start=\"1962\" data-end=\"2201\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1962\" data-end=\"2201\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1962\" data-end=\"2201\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-start=\"2203\" data-end=\"2625\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975771966,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Sermorelin_GHRP-2_5_5mg_a625ffeb-080c-4983-90c6-762231180224.png?v=1768874020"},{"product_id":"sermorelin-ghrp-6-blend","title":"Sermorelin, GHRP-6 Blend","description":"\u003cp data-end=\"751\" data-start=\"145\"\u003eSermorelin \/ GHRP-6 Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Sermorelin and Growth Hormone–Releasing Peptide-6 (GHRP-6). Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), while GHRP-6 is a growth hormone secretagogue receptor (GHS-R) agonist originally developed as a hexapeptide. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1470\" data-start=\"753\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Sermorelin has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a relatively short duration of activity. GHRP-6 has been widely researched for its role in ghrelin receptor activation and its influence on growth hormone secretion amplitude and frequency. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion dynamics, and endocrine signaling coordination.\u003c\/p\u003e\n\u003cp data-end=\"2012\" data-start=\"1472\"\u003eCurrently, the Sermorelin \/ GHRP-6 Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, appetite-related hormone interactions, and circadian growth hormone release patterns. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2012\" data-start=\"1472\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2012\" data-start=\"1472\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2253\" data-start=\"2014\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2677\" data-start=\"2255\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975804734,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Sermorelin_GHRP-6_5_5mg_6ef71b64-2300-489e-965a-019cbb264894.png?v=1768874021"},{"product_id":"sermorelin-ghrp-6-ghrp-2-blend","title":"Sermorelin, GHRP-6, GHRP-2 Blend","description":"\u003cp data-end=\"823\" data-start=\"145\"\u003eSermorelin \/ GHRP-6 \/ GHRP-2 Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Sermorelin, Growth Hormone–Releasing Peptide-6 (GHRP-6), and Growth Hormone–Releasing Peptide-2 (GHRP-2). Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), while GHRP-6 and GHRP-2 are growth hormone secretagogue receptor (GHS-R) agonists with differing receptor activity profiles. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1654\" data-start=\"825\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Sermorelin has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a relatively short duration of activity. GHRP-6 has been widely researched for its role in ghrelin receptor activation and its influence on growth hormone secretion amplitude and frequency, while GHRP-2 has been examined for its potent receptor binding and effects on growth hormone release dynamics. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion amplitude, and endocrine signaling coordination.\u003c\/p\u003e\n\u003cp data-end=\"2205\" data-start=\"1656\"\u003eCurrently, the Sermorelin \/ GHRP-6 \/ GHRP-2 Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, appetite-related hormone interactions, and circadian growth hormone release patterns. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2205\" data-start=\"1656\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2205\" data-start=\"1656\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2446\" data-start=\"2207\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2870\" data-start=\"2448\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975837502,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Sermorelin_GHRP-6_GHRP-2_Blend_c9133232-cbdc-4319-b85e-a7d57d370e96.png?v=1768874022"},{"product_id":"sermorelin-ipamorelin-blend","title":"Sermorelin, Ipamorelin Blend","description":"\u003cp data-end=\"698\" data-start=\"145\"\u003eSermorelin \/ Ipamorelin Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Sermorelin and Ipamorelin. Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1388\" data-start=\"700\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Sermorelin has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a relatively short duration of activity. Ipamorelin has been examined for its selective receptor activity and minimal interaction with other pituitary hormones. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion dynamics, and endocrine signaling coordination.\u003c\/p\u003e\n\u003cp data-end=\"1931\" data-start=\"1390\"\u003eCurrently, the Sermorelin \/ Ipamorelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, circadian hormone release patterns, and coordinated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"1931\" data-start=\"1390\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"1931\" data-start=\"1390\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2172\" data-start=\"1933\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2596\" data-start=\"2174\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975903038,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Sermorelin_Ipamorelin_5_5mg_42a5f9e2-6cf4-47f8-b612-74dc2508b9d2.png?v=1768874024"}],"url":"https:\/\/nordscipeptides.com\/collections\/peptide-blends-copy.oembed","provider":"Nordsci","version":"1.0","type":"link"}